Compounds > rosiglitazone
Page last updated: 2024-08-25

rosiglitazone and sr141716

rosiglitazone has been researched along with sr141716 in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's5 (71.43)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Abell, L; Ahmad, S; Apedo, A; Azzara, AV; Brigance, R; Chang, S; Chao, H; Chen, L; Cheng, D; Chu, CH; Cullen, MJ; Dabros, M; Devasthale, P; Dierks, E; Foster, K; Gao, Q; Hangeland, JJ; Harden, D; Harvey, S; Hou, X; Keim, WJ; Kempson, J; Kopcho, L; Lawrence, RM; Li, YX; Ma, Z; Mathur, A; Meng, W; Moore, F; O'Malley, K; Panemangelor, R; Pelleymounter, MA; Robl, JA; Rooney, S; Turdi, H; Wang, W; Whaley, JM; Wu, DR; Ye, XY; Zhao, G1
Esposito, K; Giugliano, D1
Choi, JM; Jin, SM; Kim, JH; Kim, KW; Lee, S; Oh, BJ; Park, CY; Park, SW; Yang, SJ1
Balvers, MG; Dwarkasing, J; Lute, C; Meijerink, J; Plastina, P; Poland, M; van Norren, K; Witkamp, RF1

Other Studies

7 other study(ies) available for rosiglitazone and sr141716

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic Disorders.
    Journal of medicinal chemistry, 2021, 10-14, Volume: 64, Issue:19

    Topics: Animals; Crystallography, X-Ray; Drug Discovery; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Metabolic Diseases; N-Acetylglucosaminyltransferases; Structure-Activity Relationship

2021
Optimal treatments for the metabolic syndrome.
    Arteriosclerosis, thrombosis, and vascular biology, 2006, Volume: 26, Issue:4

    Topics: Anti-Obesity Agents; Cardiovascular Diseases; Complementary Therapies; Diabetes Mellitus; Diet; Health Behavior; Humans; Hypoglycemic Agents; Life Style; Metabolic Syndrome; Metformin; Obesity; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Rosiglitazone; Thiazolidinediones

2006
Reduced food intake is the major contributor to the protective effect of rimonabant on islet in established obesity-associated type 2 diabetes.
    Yonsei medical journal, 2013, Volume: 54, Issue:5

    Topics: Adiponectin; Adiposity; Animals; Cell Proliferation; Diabetes Mellitus, Type 2; Eating; Glucose Intolerance; Insulin Resistance; Insulin-Secreting Cells; Male; Piperidines; Pyrazoles; Rats; Rats, Inbred OLETF; Receptor, Cannabinoid, CB1; Rimonabant; Rosiglitazone; Thiazolidinediones

2013
Inhibition of COX-2-mediated eicosanoid production plays a major role in the anti-inflammatory effects of the endocannabinoid N-docosahexaenoylethanolamine (DHEA) in macrophages.
    British journal of pharmacology, 2015, Volume: 172, Issue:1

    Topics: Anilides; Animals; Arachidonic Acids; Camphanes; Cell Line; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dehydroepiandrosterone; Dinoprostone; Endocannabinoids; Indenes; Interferon-beta; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myeloid Differentiation Factor 88; NF-kappa B; Nitric Oxide; Piperidines; PPAR gamma; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Rosiglitazone; Thiazolidinediones; Toll-Like Receptor 3; Toll-Like Receptor 4

2015